Register for the 2018 Post Graduate Convention

Register Here!

2018 PGC Invitation

Download Registration Form

2018 Exhibitor

Exhibitors Register Here!

Download Exhibitor Form



World Forestry Center 4033 SW Canyon Road, Portland, Oregon

March 9, 2018 – 8:00am to 5:00pm (President’s Reception in the Museum at 5:00pm – 7:00pm)

March 10, 2018 – 7:30am to 3:30pm

Target Audience/Program Focus

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Ophthalmology and the Oregon Academy of Ophthalmology. The American Academy of Ophthalmology is accredited by the ACCME to provide continuing medical education for physicians.


The American Academy of Ophthalmolgy designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity.


FACULTY FOR THE 2018 – Post Graduate Convention: The Leading Voices in Ophthalmology

Ronald Gross, MD

Ronald Gross, MD

Professor and Chair, WVU Eye Institute, Dept. of Ophthalmology Morgantown,
West Virginia

David Lubeck, MD

David Lubeck, MD

Partner, Arbor Centers for EyeCare
Homewood, Illinois

Bronwyn Hamilton, MD

Bronwyn Hamilton, MD

Professor of Diagnostic Radiology,
Division of Nuclear Medicine,
School of Medicine Oregon Health & Science University
Portland, Oregon

Mark Lucarelli, MD

Mark Lucarelli, MD

University of Wisconsin – Dept. of Ophthalmology and Visual Sciences
Madison, Wisconsin

Steven Yeh, MD

Steven Yeh, MD

Director, Section of Uveitis and Vasculitis
Emory Eye Center
Atlanta, Georgia

Agenda – Post Graduate Convention [subject to change]

Friday, March 9, 2018

8:00 – 8:05 AM President’s Welcome Jonathan Kemp, MD
8:05 – 8:45 AM  Glaucoma Evaluation of the Optic Nerve and Visual Field – the New and the Old Ronald Gross, MD
8:45 – 9:25 AM Evaluation and Management of Ptosis – Pearls for the Office and Operating Room Mark Lucarelli, MD
9:25 – 10:05 AM Surgeon Health; Practice Patterns and Disciplines to Maximize Efficiency, Concentration, Well-being, and Longevity David Lubeck, MD
10:05 – 10:25 AM Break and Exhibitor Visits
10:25 – 11:05 AM Ebola, Zika, and Emerging Infectious Diseases of the Eye Steven Yeh, MD
11:05 – 11:45 PM The Fundus as a Vital Sign Ronald Gross, MD
11:45 – Noon Annual Business Meeting
Noon – 1:00 PM Lunch
1:00 – 1:40 PM Botulinum Toxin for Facial Synkinesis Mark Lucarelli, MD
1:40 – 2:40 PM Neuro-radiology Relevant to Ophthalmology Bronwyn Hamilton, MD
2:40 – 3:00 PM Break and Exhibitor Visits
3:00 – 3:40 PM Tips and Techniques to Improve Efficiency in Cataract Surgery David Lubeck, MD
3:40 – 4:20 PM Advances in the Management of Noninfectious Uveitis Steven Yeh, MD
4:20 – 5:00 PM Glaucoma Screening and Telemedicine Ronald Gross, MD
5:00 PM President’s Reception in the Museum

Saturday, March 10, 2018

7:30 AM Breakfast Buffet Served in Exhibitor Hall
8:00 – 8:40 AM Oculofacial Cosmetic Techniques and Surgery – A Basic Overview Mark Lucarelli, MD
8:40 – 9:40 AM WORKSHOP: FLACS AND IOL Fixation for Complex or Unstable Cataracts David Lubeck, MD
9:40 – 10:20 AM Perioperative Management of Uveitic Cataract  Steven Yeh, MD
10:20 – 10:40 AM Break and Exhibitor Visits
10:40 – 11:40 AM WORKSHOP: Blue Sclera in Glaucoma Ronald Gross, MD
11:40 – 12:20 PM The Cost of Cataract Surgery; An Analysis of the True Costs to Evaluate, Educate and Operate on Cataract Patients David Lubeck, MD
12:20 – 1:20 PM Lunch
1:20 – 2:20 PM WORKSHOP: Infections and Injections Steven Yeh, MD
2:20 – 3:20 PM WORKSHOP: Orbital Unknowns – Interactive Clinical Pathologic Cases  Mark Lucarelli, MD
3:20 PM  Adjourn


  • Identify a systematic method to detect glaucomatous optic disc and nerve fiber layer damage.
  • Use a standard methodology to interpret results of standard automated perimetry.
  • Distinguish the impact of variability and timing of automated perimetry on the ability to detect progression.
  • Recognize the ability of retinal vasculature to reflect systemic implications.
  • Identify the different measures of vascular structure.
  • Recognize the impact of changes in vascular caliber – arteriolar and venular on complications of diabetes.
  • Recognize the impact of changes in retinal vascular parameters on systemic disease risk.
  • Formulate the criteria for screening for glaucoma, specifically the need for a highly specific method.
  • Prioritize the strengths and weakness of current screening modalities including IOP, structure, and function.
  • Identify the potential of using optic nerve and RNFL imaging for remote evaluation.
  • Recognize developmental secondary glaucomas.
  • Recognize progressive scleral thinning and the relationship to elevated IOP.
  • Identify the possible role(s) and advantages of tissue adhesives in tube shunt surgery.
  • Have improved ability and confidence evaluating patients with eyelid ptosis.
  • Identify the features of involutional and myogenic ptosis.
  • Be able to prioritize the most common surgical options for management of involutional ptosis.
  • Distinguish the common symptoms of patients with facial synkinesis.
  • Identify the anatomic basis of the common patterns of facial synkinesis.
  • Use recent trends in cosmetic surgery utilization.
  • Identify the most commonly utilized office-based cosmetic oculofacial techniques.
  • Recognize options for aesthetic oculofacial surgical techniques.
  • Hone skills of diagnosing orbital disorders.
  • Distinguish diagnosis and management several common orbital inflammatory and neoplastic disorders.
  • Recognize how to use CT and MR imaging of orbital disease, including MR angiography.
  • Identify standard neuroimaging modalities and which imaging and sequences are appropriate for various indications/clinical scenarios.
  • Distinguish the basics of neuroimaging interpretation using an interactive case review type format.
  • Recognize the ophthalmic manifestations of Ebola, Zika and emerging infectious diseases of global health consequence and implications for ophthalmologists domestically and internationally.
  • Identify local corticosteroid delivery for the treatment of non-infectious uveitis
  • Identify Phase 3 Trials related to local and systemic immunomodulatory agents for the treatment of non-infectious uveitis.
  • Prioritize perioperative management strategies for patients with uveitic cataract.
  • Assess risk of uveitic flare-up in patients with uveitis syndromes and how that may contribute to varying perioperative regimens.
  • Prioritize combination systemic and intravitreal antiviral therapy for herpetic retinitis/ acute retinal necrosis.
  • Recognize complex cases of infectious uveitis and their management. Identify physical situations or positioning that could cause self-injury and implement strategies or devices to prevent such injuries
  • Distinguish intellectual traits and patterns that can limit physician concentration and implement strategies to improve focus and productivity.
  • Identify stressors that can cause a decline in emotional health and implement strategies and treatment to improve psychological wellbeing.
  • Formulate strategies to increase preoperative, OR, and postoperative efficiency.
  • Identify improvements in equipment that can make cataract surgery safer and more efficient.
  • Consider the use of adjunctive technologies to improve outcomes or treat co-morbid disease.
  • Categorize all practice resources required to perform cataract surgery.
  • Be able to do a comprehensive analysis of costs in their practices.
  • Consider strategies to improve profitability of performing cataract surgery.
  • Implement strategies to perform cataract surgery with lens implantation in complex situations.
  • Use updated instrumentation to facilitate complex surgery.
  • Consider use of the femtosecond laser to facilitate complex surgery.
  • Integrate various IOL fixation techniques for different levels of capsular stability.

Faculty Disclosure Policy

All faculty members and planning committee members participating in this educational program are expected to disclose to the program audience any significant financial interest and/or other relationship with the manufacturers and providers of commercial products and/or services discussed in their presentation, and their relationship or financial interest in any commercial contributor to the educational activity.